Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment

Catheter Cardiovasc Interv. 2021 Mar;97(4):579-580. doi: 10.1002/ccd.29573.

Authors

Kellan E Ashley^{1

2}, William B Hillegass^{2

3}

Affiliations

¹ Department of Interventional Cardiovascular Disease, University of Mississippi Medical Center, Jackson, Mississippi, USA.
² Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
³ Departments of Data Science, University of Mississippi Medical Center, Jackson, Mississippi, USA.

PMID: 33721413
DOI: 10.1002/ccd.29573

No abstract available

Publication types

Editorial
Comment

MeSH terms

Clopidogrel
Humans
Judgment
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors* / adverse effects
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Clopidogrel